Sharesmagazine
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 
You are NOT currently logged in
Register now or login to post to this thread.

Sareum (SAR)     

3 monkies - 08 Feb 2011 19:17

RHPS has just mentioned the above in an e-mail, they have gone up 240% today - started at 0.60 and finished up at 1.65. Look to be quite interesting.

Toya - 06 Mar 2011 09:41 - 87 of 224

Certainly a good result at last for this little bioco. I held years ago but then sold as it seemed to be running out of cash. P'raps time to get back in now?

tabasco - 06 Mar 2011 12:18 - 88 of 224

I like this post from another bb.... Opinion: Strong Buy
Price: 2.38
My Views on Sareum..in a nutshellToday 02:27

(a) It is currently oversold after spike in mid Feb and the market cap is still low at 28-32 million ...say compared to Phytopharm with a single 43% Phase 2 cure for Parkinsons and capitalised at a couple of million more

(b) The trial results are exceptional - 1 in 100 potentially successful drugs fails to get to pre-clinicals...the fallout for Phase 1-3 is statistically less and usually the pre-clinical gives a hint of failure eg 20% efficicacy..here we have a PRE CLINICAL 100% cure, see (f) for the reason why... which is the real reason for us all to stay invested

(c) Cancer cures is a potentially multibillion market

Now for the biggies

(d) despite the buzz on here probably no more than 30,000 people in a world of 7 billion are FULLY aware of the signifigance of their methodology and the outcome of the trials.. as the news spreads the investment will increase dramatically

(e) The company has no major institutional holders...with its sudden burst in size all the AIM / small cap funds need to buy some and they should by now all be tightly held by PI's who have seen 100-200% gains and haven't taken thethe profit REASON they have reached the logical conclusion that this is a multibagger like no other.... so demand will exceed supply and the price must therefore rise almost inexorably....well to the point where everyone can see the emperor is bare....this could after all be the South Sea Bubble of the 21st century!!

(e) The company is not a one trick pony..the second RNS confirms the power of the STIL platform....from the identification of a problem to tackle and the formulation of a strategy to preclinical success takes on average 6-8 years....SAR floated in late 2004 so 2011-3 is the period when the initial products will come home to roost...this is the first two of the initial products and there is a pipeline of other targets which they have started to tackle over the last 6 years which we are not including in the valuation

(f) The biggest asset the company has is the technology to identify the disease cause and the molecule to solve it...this can be rolled out for hundreds of diseases....the building of the magic bullet and the testing of it are time consuming but relatively simple....so in effect YOU ARE NOT investing in a cure for myeloid luekemia but rather in a cloud factory to produce the CURES to many diseases.....and healthcare is the only part of the economy in the UK or the world which is not being cut back at the moment

IN SUMMARY SAREUM's DIAGNOSIS AND DESIGN PROCEDURE IS BIGGER THAN E-PROCUREMENT / RDIF / ALTERNATIVE ENERGY and SCARCE MINERAL RESOURCES PUT TOGETHER.

DYOR

required field - 06 Mar 2011 15:49 - 89 of 224

Going by this : 5 to 10p next week ?....I'd like to think so, but surely a rise by a penny is in the running on monday .....hope so...

kimoldfield - 06 Mar 2011 16:50 - 90 of 224

Is Tabby in these? We are sunk if he is! ;o)

Nah! Only joking Tabs! :0)

SAR has a very good chance of strong interest from potential licencees now. Nothing guaranteed as always with research companies like this, but it cannot be ruled out as a potential 10+ bagger from here on.

driver - 06 Mar 2011 17:14 - 91 of 224

required field

This could go anywhere but I would keep my finger over the sell button If I were you, This is being ramped by day traders, keep in mind SAR has a bigger M/Cap than ASM who have 23m in cash and five products on the go not holding either by the way just an observation.

kimoldfield - 06 Mar 2011 17:29 - 92 of 224

A bit of a sob story for you Driver. I have been in these for longer than i care to remember. On Feb 9th the sp flew and I decided to sell a majority of my holding for 4.6p having bought substantially lower; pressed sell and sat back with a satisfied grin, at which there was a flash and a bang and the electric cut off. By the time the power had been restored the sp had fallen to 3.1p and my sell order had failed! Sold at that price, without a grin! Still holding 150k. Not a lot but staying with the potential. (Ramped or otherwise!)

driver - 06 Mar 2011 17:32 - 93 of 224

kim
LOL Stick with it, Good Luck

tabasco - 06 Mar 2011 18:07 - 94 of 224

Kim.I am Mr. luckyyou should know thathad my best year ever last yearand this year has started the same.
First of all let me thank 3 monkies for putting this dog back on my radarthank you!...
10 years back I was invested in millennium pharmaceuticals on the nasdaqI dont even know if they are still going?...around 2003 they pulled out of the UK and SER were spun outI yhink?...those with better knowledge can correct mewhat a bad stockbegged, borrowed, gifted moneydownsized operations.you name it investors covered it
Then on the 07/02/11 we had the positive results from leukaemia studythey looked good and made a few of us take noticesome paid over 4ptoo bigger risk for me
After tgree big daysthe price kept dropping..why?
Kim when the SP flunked to 1.30p on no other newsI thought it was fcuking mentaland took a punt
Within a few days down to 1-05pI thought I was fcuking mentalthen came the second bit of good news Dr Tim Mitchell, commented: "These are exciting advances, demonstrating efficacy of our Chk1 compounds in several cancer models. Studies on additional models are on-going.
I dont believe in coincidencesthis works in two types of cancer.fact!!!
Kimwith me investedyou should feel lucky.I have spoken to a guy today that assists in my luckhe reckons it will hit 4p tomorrow at some stageenjoy the ride!

3 monkies - 06 Mar 2011 18:44 - 95 of 224

Thanks for giving me an acknowledgement tabasco - will try and buy some more early tomorrow to get my initial awful price down which the delightful Halifax made me pay. Very hard to trade last Friday - would not let me execute a trade again and I certainly wasn't leaving it up to them again!!!!! Good luck all and if I make a profit on this I shall certainly donate some of it to Cancer Research. Don't know now whether I should have got out of PYC.

kimoldfield - 06 Mar 2011 19:28 - 96 of 224

I hope you all turn out winners. Oh, and me too!

required field - 07 Mar 2011 08:04 - 97 of 224

It's what I suspected : going ballistic....

gibby - 07 Mar 2011 08:31 - 98 of 224

morning all - another good day - plenty of press over the weekend & from the other side:

'I sent another email to Claire Noyce of Hybridan. My Email: Hi Claire, Thanks for your reply, but Tim put me onto yourselves! Can you at least let me know how often brokers target prices are reviewed as Sareum is now well out of date? Kind Regards xxxxx

Claire's reply last night: Dear xxxxx, Again, it is very difficult for me to comment in detail. To keep this non stock specific, i would make two comments. One: there is no rule here defining when a broker needs to move his target and two:Companies don't always want research written for various reasons it might not be the right time. Best regards Claire Noyce

I read this as Sareum asking Hybridan not to report yet and probably because they want the latest RNS to run its course and also they are very close to a deal, which will then make it easier to re-rate the stock! GLA today'

onwards & upwards!!

driver - 07 Mar 2011 16:37 - 99 of 224

3 monkies

Did you buy more.

3 monkies - 07 Mar 2011 16:54 - 100 of 224

Oh! yes, brought my spread down to 3.20 thought I had waited long enough for them to drop after the rise .......... guess what - didn't wait long enough, but that is typical of me but if there is good news to come I am sure it will come right. Hey ho!

kimoldfield - 07 Mar 2011 16:57 - 101 of 224

I had my finger hovering over the sell button at 3.1p when L2 was indicating that the sp was going to go ar*e up but did nothing, should have sold and bought back at 2p but there you go. Didn't do it! A bit premature to sell though; if licencees are not forthcoming in the next couple of months then maybe there is a rough ride for SAR ahead. Can't see it at the moment though, these rose tinted specs are pretty strong! :o)

3 monkies - 07 Mar 2011 17:07 - 102 of 224

I think I need my head testing as well as the eyes kim - I just hope they do well for the people who suffer and a little profit for me and all of us and certainly some for them. As far as the head testing goes - no comments please I know I'm bonkers........

kimoldfield - 07 Mar 2011 17:13 - 103 of 224

Oh, I'm sure you're not bonkers 3M just, like me, slightly deluded on occasion! ;o)

Yes, SAR are doing some sterling work to try to find cancer cures, let's hope they have many successes in the future.

3 monkies - 07 Mar 2011 17:32 - 104 of 224

Just laughing at myself and thinking perhaps I should have left it up to the Halifax to buy for me they would have probably got them for 0.40 'si less than I did. haha!!

driver - 07 Mar 2011 17:37 - 105 of 224

Im not going to comment.


The Company announces that Mr Tim Mitchell, Chief Executive Officer of Sareum,
has today sold a total of 500,000
.
http://moneyam.uk-wire.com/cgi-bin/articles/20110307172000H5143.html

3 monkies - 07 Mar 2011 17:40 - 106 of 224

Good on you driver - I don't need you to.
Register now or login to post to this thread.